Please use this identifier to cite or link to this item:
|Title:||Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future.|
Uterine Cervical Neoplasms
Clinical Trials as Topic
|Citation:||Int. J. Gynecol. Cancer.2016 Jan;(26)1:199-207|
|Abstract:||Cervical cancer is responsible for more than a quarter of a million deaths globally each year, mostly in developing countries, making therapeutic advances in all health care settings a top priority. The Gynecologic Cancer InterGroup (GCIG) is a worldwide collaboration of leading national research groups that develops and promotes multinational trials in gynecologic cancer. In recognition of the pressing need for action, the GCIG convened an international meeting with expert representation from the GCIG groups and selected large sites in low- and middle-income countries.|
|Appears in Collections:||Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.